Recombinant Human NEFH Protein, N-GST & C-His

Description of Recombinant Human NEFH Protein, N-GST & C-His

Structure of Recombinant Human NEFH Protein

Recombinant Human NEFH Protein, also known as Neurofilament Heavy Polypeptide, is a protein that is encoded by the NEFH gene in humans. It is a member of the intermediate filament family of proteins and is predominantly found in nerve cells. The protein has a molecular weight of approximately 200 kDa and is composed of three subunits – a 102 kDa head, a 54 kDa rod, and a 45 kDa tail.

The head and tail regions of the protein are highly charged and contain multiple phosphorylation sites, while the rod region is mainly composed of alpha-helical coiled-coil domains. These domains are responsible for the structural stability and flexibility of the protein.

Activity of Recombinant Human NEFH Protein

Recombinant Human NEFH Protein plays a crucial role in maintaining the structural integrity and function of neurons. It is a major component of the neuronal cytoskeleton and is involved in axonal growth, transport of cellular components, and signal transduction.

The phosphorylation of NEFH is important for regulating its activity, as it affects the interactions between different intermediate filaments and microtubules. This, in turn, influences the stability and dynamics of the cytoskeleton, which is essential for proper neuronal function.

Application of Recombinant Human NEFH Protein

The recombinant form of NEFH protein has a wide range of applications in the field of neuroscience and neurodegenerative diseases. One of its primary uses is as an antigen for the production of specific antibodies. These antibodies can be used for various research purposes, such as studying the distribution and expression of NEFH in different tissues.

Moreover, recombinant NEFH protein can also be used as a standard in immunoassays for the quantification of NEFH levels in biological samples. This is particularly useful in the diagnosis and monitoring of neurodegenerative diseases, as changes in NEFH levels have been linked to conditions such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis.

In addition, recombinant NEFH protein has the potential to be used in therapeutic interventions for neurodegenerative diseases. Studies have shown that NEFH levels are decreased in these conditions, and supplementing with recombinant NEFH may help restore the structural and functional integrity of neurons.

Furthermore, the ability of NEFH to promote axonal growth and regulate neuronal signaling makes it a promising candidate for nerve regeneration therapies. Recombinant NEFH protein can be used to enhance the growth and repair of damaged nerve cells, potentially providing new treatment options for spinal cord injuries and other nerve-related disorders.

In conclusion, Recombinant Human NEFH Protein is a crucial component of the neuronal cytoskeleton, with diverse roles in maintaining neuronal structure and function. Its recombinant form has numerous applications in research, diagnostics, and potential therapeutics for neurodegenerative diseases. Further studies on this protein may lead to new insights and treatments for various neurological disorders.